<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               17 PATIENT COUNSELING INFORMATION<BR>               <BR>                  <BR>                     See FDA-Approved Patient Labeling<BR>                     <BR>                  <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.1 Premenopausal Women<BR>                     <BR>                        Patients should be advised that EXEMESTANE is not for use in premenopausal women.<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.2 Other Estrogen-Containing Agents<BR>                     <BR>                        Patients should be informed that they should not take estrogen-containing agents while they are taking EXEMESTANE as these could interfere with its pharmacologic action.<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.3 Bone Effects<BR>                     <BR>                        Patients should be informed that EXEMESTANE lowers the level of estrogen in the body. This may lead to reduction in bone mineral density (BMD) over time. The lower the BMD, the greater the risk of osteoporosis and fracture.<BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>